Manufacturer record
GNB Medica Labs: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by GNB Medica Labs (Himachal Pradesh) were declared Not of Standard Quality between October 2019 and October 2019. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to GNB Medica Labs in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefixime Dispersible Tablets (SAMCEF- 200DT TABLETS) | TF19-88Mfg 2019-06 · Exp 2021-05 | Uniformity of dispersion and DisintegrationDisintegration | RDTL ChandigarhCDSCO lab | Oct 2019 |
| Amoxycillin and Potassium Clavulanate with Lactic Acid Bacillus Tablets (ANUMOX- CV-LB TABLETS) | TG19-36Mfg 2019-07 · Exp 2020-12 | AssayAssay | RDTL ChandigarhCDSCO lab | Oct 2019 |
| Amoxycillin and Potassium Clavulanate Tablets IP (ICLAVE-625 TABLETS ) | TG19-32Mfg 2019-07 · Exp 2020-12 | Dissolution and AssayAssay | RDTL ChandigarhCDSCO lab | Oct 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.